Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-092155

Chief Financial Officer acquired 794 shares (grant or award)

  • Chief Financial Officer gave up 96 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2026-03-02 Grant or award +397 $35.97 $14,280 14,956 D
Mokari Atabak Chief Financial Officer 2026-03-02 Grant or award +397 15,353 D
Mokari Atabak Chief Financial Officer 2026-03-03 Shares withheld for taxes −96 $35.97 $3,453 15,257 D
Loading xslF345X05/ownership.xml…